These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3018406)

  • 1. Kappa receptor mediated opioid dependence in rhesus monkeys.
    Gmerek DE; Woods JH
    Life Sci; 1986 Sep; 39(11):987-92. PubMed ID: 3018406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
    Gmerek DE; Dykstra LA; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.
    Tang AH; Collins RJ
    Psychopharmacology (Berl); 1985; 85(3):309-14. PubMed ID: 3923516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
    Fukagawa Y; Katz JL; Suzuki T
    Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of kappa opioids on cocaine self-administration by rhesus monkeys.
    Negus SS; Mello NK; Portoghese PS; Lin CE
    J Pharmacol Exp Ther; 1997 Jul; 282(1):44-55. PubMed ID: 9223538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):334-42. PubMed ID: 1309877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
    Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
    Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
    Gmerek DE; Woods JH
    J Pharmacol Exp Ther; 1985 Nov; 235(2):296-301. PubMed ID: 4057071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys.
    Katz JL; Woods JH; Winger GD; Jacobson AE
    Life Sci; 1982 Nov 15-22; 31(20-21):2375-8. PubMed ID: 6298529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory effects of receptor-selective opioids in rhesus monkeys.
    France CP; Woods JH
    Prog Clin Biol Res; 1990; 328():295-8. PubMed ID: 2154784
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
    Ignar DM; Kuhn CM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.